Anti-TNF alpha in the treatment of psoriatic arthritis

被引：5
|
作者：
Claudepierre, P
Wendling, D
Cohen, JD
机构：
[1] CHU Henri Mondor, Serv Rhumatol, F-94010 Creteil, France
[2] CHU Jean Mindoz, Serv Rhumatol, Besancon, France
来源：
PRESSE MEDICALE | 2006年 / 35卷 / 04期
关键词：
D O I：
10.1016/S0755-4982(06)74658-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Psoriatic arthritis is on inflammatory and possibly destructive form of arthritis. As in rheumatoid arthritis and ankylosing spondylitis, the use of biological therapy in psoriatic arthritis is a therapeutic revolution: both articular and cutaneous efficacy have been shown, and some improvement is visible on radiography. The benefit-risk ratio will improve when we learn to identify more accurately the patients likely to benefit from these treatments.
引用
收藏
页码：647 / 655
页数：9
相关论文
共 50 条
  • [21] Immune cell activity during anti-TNF treatment in patients with psoriasis and psoriatic arthritis
    Petrovic, Aleksandra
    Samuelsen, Victoria Marie
    Davies, Richard
    Aarebrot, Anders K.
    Holmes, Timothy
    Sarkar, Irene
    Bergum, Brith
    Jonsson, Roland
    Sandvik, Lene F.
    Solberg, Silje M.
    Appel, Silke
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2024,
  • [22] THE EFFECT OF ANTI-TNF TREATMENT IN PSORIATIC ARTHRITIS PATIENTS TREATED IN AN ORDINARY CLINICAL PRACTICE
    Haugeberg, G.
    Gulati, A. M.
    Diamantopoulos, A. P.
    Gabrielsen, K. H.
    Hoff, M.
    Kavanaugh, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 967 - 967
  • [23] PERSISTENCY WITH SUBCUTANEOUS ANTI-TNF THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Waters, H.
    Olson, W.
    Bolge, S.
    Gunnarsson, C.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A41 - A41
  • [24] Safety of Anti-TNF Alpha Agents in the Pregnant Psoriatic Patient
    Shallcross, Laurie K.
    Driscoll, Marcia S.
    [J]. CURRENT DRUG THERAPY, 2013, 8 (01) : 45 - 58
  • [25] ANTINUCLEAR ANTIBODIES IN RHEUMATOID ARTHRITIS: PREDICTORS OF RESPONSE TO ANTI-TNF ALPHA TREATMENT?
    Fonseca, R.
    Vieira, R.
    Madureira, P.
    Rosa-Goncalves, D.
    Aguiar, F.
    Rocha, T.
    Bernardo, A.
    Mariz, E.
    Bernardes, M.
    Costa, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1293 - 1293
  • [26] An open study of the anti-TNF alpha agent pentoxifylline in the treatment of rheumatoid arthritis
    Dubost, JJ
    Soubrier, M
    Ristori, JM
    Beaujon, G
    Oualid, T
    Bussiere, JL
    Sauvezie, B
    [J]. REVUE DU RHUMATISME, 1997, 64 (12): : 789 - 793
  • [27] Alternative for Anti-TNF Antibodies for Arthritis Treatment
    Paquet, Joseph
    Henrionnet, Christel
    Pinzano, Astrid
    Vincourt, Jean-Baptiste
    Gillet, Pierre
    Netter, Patrick
    Chary-Valckenaere, Isabelle
    Loeuille, Damien
    Pourel, Jacques
    Grossin, Laurent
    [J]. MOLECULAR THERAPY, 2011, 19 (10) : 1887 - 1895
  • [28] Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritis
    Pirowska, Magdalena M.
    Gozdzialska, Anna
    Lipko-Godlewska, Sylwia
    Obtulowicz, Aleksander
    Sulowicz, Joanna
    Podolec, Katarzyna
    Wojas-Pelc, Anna
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2015, 32 (04): : 250 - 254
  • [29] HOW ENTHESITIS AND DACTYLITIS IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS RESPOND TO ANTI-TNF TREATMENT?
    Kelsall, J.
    Choquette, D.
    Arendse, R.
    Rahman, P.
    Zummer, M.
    Avina-Zubieta, J. A.
    Rampakakis, E.
    Psaradellis, E.
    Maslova, K.
    Osborne, B.
    Nantel, F.
    Lehman, A. J.
    Tkaczyk, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 784 - 784
  • [30] Eligibility for anti-TNFα therapy in a psoriatic arthritis out patient cohort
    Kyle, SD
    Solanki, K
    Carmichael, C
    McHugh, NJ
    [J]. RHEUMATOLOGY, 2005, 44 : I114 - I114
12345